Glucagon Like Peptide 1 Analogs Market Estimated to Witness Strong Growth Fueled by Increasing Prevalence of Diabetes
Glucagon like peptide 1 (GLP-1) analogs are injectable drugs that help control blood sugar levels in patients with type 2 diabetes. GLP-1 analogs work by stimulating the release of insulin from the pancreas and suppressing the release of glucagon which helps lower blood glucose levels. They also help slow the emptying of the stomach and promote satiety, helping patients lose weight as obesity is a leading risk factor for diabetes.
The Global Glucagon Like Peptide 1 Analogs Market is estimated to be valued at US$ 12.5 Billion in 2024 and is expected to exhibit a CAGR of 5.8% over the forecast period 2024 To 2031.
Get More Insights on Glucagon Like Peptide 1 Analogs Market (https://www.insightprobing...
Glucagon like peptide 1 (GLP-1) analogs are injectable drugs that help control blood sugar levels in patients with type 2 diabetes. GLP-1 analogs work by stimulating the release of insulin from the pancreas and suppressing the release of glucagon which helps lower blood glucose levels. They also help slow the emptying of the stomach and promote satiety, helping patients lose weight as obesity is a leading risk factor for diabetes.
The Global Glucagon Like Peptide 1 Analogs Market is estimated to be valued at US$ 12.5 Billion in 2024 and is expected to exhibit a CAGR of 5.8% over the forecast period 2024 To 2031.
Get More Insights on Glucagon Like Peptide 1 Analogs Market (https://www.insightprobing...
2 months ago
